ResMed Inc. (RMD)
FlaggedUS listed · Healthcare · Medical Instruments & Supplies
This page tracks ResMed Inc. (RMD) with live price data, technical indicators (RSI, MACD, moving averages, Sharpe ratio), and AI-powered analysis. Our scanner continuously reviews RMD against ~5,000 North American equities — fusing market fundamentals with frontier AI to surface high-conviction opportunities before they break out.
New to these indicators? RSI, MACD, and moving averages explained — plus how AI forecasting works.
Latest AI Analysis
Updated Sep 11, 2026Screen strength 2.9Note: this signal surfaced on a moderate multi-factor composite (-2.90). The AI analysis below was cautious — preserved unedited so the reservations are visible. The pre-screen STRONG_SELL (-2.9/10) conflicts sharply with the fundamental and news backdrop: ResMed trades at 20.75x P/E on 9.8% EPS/revenue growth—not expansive—and a recent analyst note highlights a de-rating narrative (30x → 21x) disconnected from 17% EPS growth, framing the stock as undervalued. However, technical deterioration is genuine: price has fallen from $240+ (late Aug) to $216.23 today on declining momentum (Sharpe -0.31, CAGR -7.34%), MACD is bearish with a -2.849 histogram, and today's volume collapsed to 0.1x average, signaling weak participation in any move. The stock sits between its SMA-50 ($216.94) and SMA-200 ($227.85)—a transitional zone offering no clear directional conviction. A defensive beta (0.78) and stable dividend (1.25%) provide some downside insulation in a fearful market (35 Fear & Greed), but the sharp recent decline and lack of volume mean the setup remains uncertain. The contradiction between valuation/news (bullish) and technicals/momentum (bearish) warrants waiting for either a clearer technical base or confirmation of the narrative thesis before committing.
RMD AI Signal Track Record
Recent scanner signals for ResMed Inc.. Each is a point-in-time AI assessment, not a guarantee of future performance.
| Date | Signal | Screen strength | Price at signal |
|---|---|---|---|
| Sep 11, 2026 | Flagged | 2.9 | $216.23 |
| Sep 11, 2026 | Flagged | 2.9 | $216.34 |
| Sep 11, 2026 | Flagged | 2.9 | $216.69 |
| Sep 11, 2026 | Flagged | 2.9 | $217.20 |
RMD — Frequently Asked Questions
Is ResMed Inc. (RMD) a buy right now?
As of September 11, 2026, StockTracker AI's screen flags RMD as Flagged, with a ±1.9% typical 3-day move, based on its multi-factor technical screen and AI review. This is a technical screen and informational analysis, not financial advice or a recommendation to trade — confirm it against your own research and risk tolerance.
What is RMD's RSI?
RMD's 14-day RSI was 41.2 at the last scan — in neutral territory. RSI above 70 is generally considered overbought and below 30 oversold; the 40–60 band is neutral and is best read alongside trend and momentum rather than on its own.
What is the AI price forecast for RMD?
StockTracker AI generates a probability-weighted 30-day price forecast for RMD — a mathematical baseline (regression on recent prices) adjusted by an AI model for news, earnings proximity, and the current macro regime, with bull/base/bear scenarios. Sign in to generate the latest forecast.
How does StockTracker AI analyze RMD?
Each scan screens RMD on momentum, RSI, MACD, moving-average posture, Sharpe ratio, and 1-year CAGR to build a composite score, then a frontier AI model reviews the full picture — fundamentals, macro context, and recent news — to confirm or challenge the signal before it's surfaced.
Get the full picture for RMD — free.
Add RMD to a watchlist for instant scanner alerts. Run an on-demand 30-day AI price forecast. See the full historical signal track record. Free tier, no credit card.
Related stocks in Healthcare
Get scanner alerts and AI forecasts for RMD
Free tier includes daily AI analysis, charts with indicators, and a 3-stock watchlist. No credit card.
Get Started →